Multiple Sclerosis: Prevention of serious illness — Vision of a desired future for newly ascertained patients

The increased prevalence of MS worldwide and the resultant high frequency of serious illness among young adults urges that the developed methods of prophylaxis are fully tested. Reference is made to the hypothesis of a circulating toxin playing a role in disease development. Insights from basic research now in progress may expand or amend the scenario. This discussion pertains to biological reasoning and a prophylactic treatment which is able to postpone or avoid disability in MS.